Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide-Reference-Cited by-同舟云学术

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

Published:2012-02 Issue:2 Volume:18 Page:314-317
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Malard Florent,Kröger Nicolaus,Gabriel Ian H.,Hübel Kai,Apperley Jane F.,Basak Grzegorz W.,Douglas Kenneth W.,Geraldes Catarina,Jaksic Ozren,Koristek Zdenek,Lanza Francesco,Lemoli Roberto,Mikala Gabor,Selleslag Dominik,Worel Nina,Mohty Mohamad,Duarte Rafael F.

Funder

Genzyme Corp

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference20 articles.

1. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma;Freedman;Blood,1999

2. Allogeneic and autologous transplantation for chronic lymphocytic leukemia;van Besien;Leukemia,2001

3. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome;Attal;N Engl J Med,1996

4. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison;Beyer;J Clin Oncol,1995

5. Therapeutic relevance of CD34 cell dose in blood cell transplantation for cancer therapy;Siena;J Clin Oncol,2000

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends in utilization of stored cryopreserved autologous peripheral hematopoietic cells intended for a second (or beyond) autologous hematopoietic cell transplantation in patients with multiple myeloma: a single center experience;Bone Marrow Transplantation;2023-07-21

2. Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN Trials;Transplantation and Cellular Therapy;2023-03

3. Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era;Clinical Lymphoma Myeloma and Leukemia;2022-08

4. Comparison Between Standard and High Dose of G-CSF for Mobilization of Hematopoietic Progenitors Cells in Patients and Healthy Donors;Transfusion Medicine Reviews;2022-07

5. Induction therapy prior to autologous stem cell transplantation (ASCT) in newly diagnosed multiple myeloma: an update;Blood Cancer Journal;2022-03-28